Novel N-hydroxamic acid hydrazide inhibitors of TNF-α synthesis

被引：0
|
作者：
机构：
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2000年 / 10卷 / 10期
关键词：
ADAM-17; rheumatoid arthritis; TACE; TNF-alpha; TNF synthesis inhibitor;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two patent applications claim novel N-hydroxamic acid hydrazide inhibitors of TNF-alpha synthesis, that act via inhibition of the TNF-alpha-converting enzyme (TACE or ADAM-17). The hydrazides are claimed to be useful in the treatment of inflammatory diseases such as rheumatoid arthritis. The claimed sulphonylhydrazide and cyclic hydrazide derivatives both display comparable in vitro potency to Roche's clinical development lead Ro 32-7315.
引用
收藏
页码：1617 / 1621
页数：5
相关论文
共 50 条
  • [21] Heteroaryl hydroxamic acid derivatives as novel histone deacetylase inhibitors
    Shirai, Fumiyuki
    Mukoyoshi, Koichiro
    Urano, Yasuharu
    Eikyu, Yoshiteru
    Ishibashi, Naoki
    Sawada, Yuki
    Kamijo, Kazunori
    Kozuki, Yoshihiro
    Satoh, Shigeki
    Masunaga, Taro
    Ohkubo, Mitsuru
    Ohta, Mitsuaki
    Tsukamoto, Shinichi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [22] The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE
    Levin, JI
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (12) : 1289 - 1310
  • [23] SYNTHESIS OF THE HETEROCYCLIC HYDROXAMIC ACID DERIVATIVES FOR PDF INHIBITORS AS A ANTIBIOTICS
    Bandivadekar, Priyanka Vishvanath
    Phadke, Shraddha A.
    Rajput, Priya
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (06):
  • [24] Synthesis and structure-activity relationship of a novel sulfone series of TNF-α converting enzyme inhibitors
    Xue, CB
    Chen, XT
    He, XH
    Roderick, J
    Corbett, RL
    Ghavimi, B
    Liu, RQ
    Covington, MB
    Qian, MX
    Ribadeneira, MD
    Vaddi, K
    Trzaskos, JM
    Newton, RC
    Duan, JJW
    Decicco, CP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (17) : 4453 - 4459
  • [25] Design, synthesis and bioactivities of novel diarylthiophenes:: inhibitors of tumor necrosis factor-α (TNF-α) production
    Fujita, M
    Hirayama, T
    Ikeda, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (10) : 3113 - 3122
  • [26] Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors
    Gilmore, JL
    King, BW
    Harris, C
    Maduskuie, T
    Mercer, SE
    Liu, RQ
    Covington, MB
    Qian, MX
    Ribadeneria, MD
    Vaddi, K
    Trzaskos, JM
    Newton, RC
    Decicco, CP
    Duan, JJW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) : 2699 - 2704
  • [27] Synthesis and 4D-QSAR Studies of Alanine Hydroxamic Acid Derivatives as Aminopeptidase N Inhibitors
    Gao, Min
    Lv, QiaoLi
    Zhang, HouPan
    Tu, GuoGang
    MEDICINAL CHEMISTRY, 2021, 17 (06) : 658 - 666
  • [28] Design, synthesis, computational and biological evaluation of novel hydroxamic and carboxylic acid derivatives as histone decaetylase inhibitors
    Gharia, Bhavini
    Suhagia, Bhanubhai N.
    Upadhyay, Jagatkumar
    Champaneria, Richa
    Lodha, Sandesh
    Shah, Shailesh A.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2020, 59 (05): : 690 - 699
  • [29] Synthesis and characterization of some novel acid hydrazide and hydrazones
    Ghosh, Kausik
    Chaudhari, Arista
    Seth, D. S.
    ORIENTAL JOURNAL OF CHEMISTRY, 2010, 26 (03) : 1103 - 1107
  • [30] Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-α production
    Xue, CB
    He, XH
    Roderick, J
    DeGrado, WF
    Cherney, RJ
    Hardman, KD
    Nelson, DJ
    Copeland, RA
    Jaffee, BD
    Decicco, CP
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1745 - 1748
12345